Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Effects of Anticoagulant Preventive Injection in Patients With Blood Cancer [Phase 2]
Phase 2 clinical trial evaluating an anticoagulant preventive injection in patients with lymphoma or multiple myeloma has completed.
-
CLINICAL_TRIALS research · 2017-05-10Clinical Trial Update: Body Composition Changes During Stem Cell Transplantation: The Case Of Lymphoma Patients
This clinical trial update examines body composition changes during hematopoietic stem cell transplantation in lymphoma patients.
-
CLINICAL_TRIALS research · 2017-05-09Clinical Trial Update: Blood Samples From Patients on a Clinical Trial to CINV During HSCT
This is an update on a clinical trial involving collection of blood samples from patients undergoing chemotherapy-induced nausea and vomitin…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation [Phase 1]
A Phase 1 pilot study evaluating disruption of the lymphoid tumor microenvironment prior to autologous stem cell transplantation was termina…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant [Phase 3]
A Phase 3 trial of moxifloxacin to prevent bacterial infections in patients who have undergone a donor stem cell transplant was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers [Phase 2]
Phase 2 trial assessing donor peripheral stem cell transplant with fludarabine and busulfan in hematologic cancers has completed; results po…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: High-dose Etoposide Could Discriminate Patients With Refractory/Relapsed Lymphoma Benefit From APBSCT
The update reports that high-dose etoposide may help discriminate which patients with refractory or relapsed lymphoma benefit from autologou…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies [Phase 1]
Phase 1 clinical trial update investigating cord blood fucosylation to enhance homing and engraftment in patients with hematologic malignanc…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Hematological Malignancies [Phase 1]
This document reports the completion of a Phase 1 safety and pharmacology study of SNX-5422 in patients with refractory hematologic malignan…
-
CLINICAL_TRIALS research · 2017-04-25Clinical Trial Update: CAR-T Therapy in Relapsed or Refractory Haematopoietic and Lymphoid Malignancies [Phase 1]
A Phase 1 clinical trial update for a CAR-T cell therapy in relapsed or refractory hematologic malignancies. It is sponsored by Hebei Senlan…
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Rasburicase Treatment for Chemotherapy or Malignancy-Induced Hyperuricemia in Asthma/Allergy Patients
Completed trial evaluating rasburicase for chemotherapy- or malignancy-induced hyperuricemia in leukemia and lymphoma patients.
-
CLINICAL_TRIALS withdrawal · 2017-04-21Clinical Trial Update: Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma [Phase 2]
A Phase 2 trial evaluating panobinostat with high-dose gemcitabine/busulfan/melphalan and autologous stem cell transplant for refractory/rel…
-
CLINICAL_TRIALS trial_result · 2017-04-21Clinical Trial Update: Melphalan With BBBD in Treating Patients With Brain Malignancies [Phase 1]
Phase 1 trial of melphalan with blood-brain barrier disruption for brain tumors and related cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Lenalidomide After Allo Transplant [Phase 1]
A Phase 1 trial of lenalidomide after allogeneic transplant in patients with multiple myeloma or lymphoma was terminated. The update provide…
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: CD19 Targeted Chimeric Antigen Receptor T Cells for B Cell Lymphoma [Phase 1, Phase 2]
This update covers a Phase 1/2 trial evaluating CD19-targeted CAR-T cell therapy for lymphoma. The current status is not disclosed in the sn…
-
CLINICAL_TRIALS safety_alert · 2017-04-17Clinical Trial Update: Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
Clinical trial update reports methemoglobinemia risk in young patients with hematologic cancers or aplastic anemia treated with dapsone in a…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma [Phase 1]
Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of GDC-0425 with and without gemcitabine in patients with refractory…
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant [Phase 1]
A Phase 1 trial evaluating rasburicase to prevent graft-versus-host disease in patients undergoing donor stem cell transplantation; the stud…
-
CLINICAL_TRIALS safety_alert · 2017-04-07Clinical Trial Update: Emergence of Chemotherapy Related Hyperglycemia in nOn-diabetic Patients
A clinical trial update reports chemotherapy-related hyperglycemia in non-diabetic patients. The finding involves cancers including colorect…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy [Phase 1]
This Phase 1 trial update reports on transplantation using specially treated bone marrow for hematologic cancers that have not responded to …
-
CLINICAL_TRIALS withdrawal · 2017-04-04Clinical Trial Update: Delayed Effects of Treatment in Cancer Survivors (DETECS)
The DETECS clinical trial (NCT02067637) investigating delayed treatment effects in cancer survivors has been withdrawn.
-
CLINICAL_TRIALS research · 2017-04-04Clinical Trial Update: Strength and Aerobic Training in Elderly Lymphoma Patients During Chemotherapy and Its Impact on Treatment Outcomes, Patients Functioning and Biological Markers of Aging [NA]
A clinical trial is evaluating the effects of strength and aerobic training in elderly lymphoma patients undergoing chemotherapy on treatmen…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Autologous Transplant in HIV Patients (BMT CTN 0803) [Phase 2]
Phase 2 trial evaluating autologous transplant in HIV-infected patients with lymphoma; completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant [Phase 2]
Phase 2 trial evaluating donor stem cell transplantation for patients with relapsed hematologic malignancies or secondary myelodysplasia who…
-
CLINICAL_TRIALS research · 2017-03-22Clinical Trial Update: Study Evaluating the Efficacy and Safety With CAR-T Immunotherapy for CD19 Positive Lymphoma [Phase 1]
This clinical trial update describes a Phase 1 study evaluating the efficacy and safety of a CD19-targeted CAR-T therapy for lymphoma.